Overall mortality in men and women in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Journal of Medical Screening

Volumn 26, Issue 3, 2019, Pages 127-134

  Pinsky, Paul F ^a   Miller, Eric A ^a   Zhu, Claire S ^a   Prorok, Philip C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; overall mortality; randomized trial; screening

Indexed keywords

CA 125 ANTIGEN; MEMBRANE PROTEIN; MUC16 PROTEIN, HUMAN; PROSTATE SPECIFIC ANTIGEN;

AGED; BLOOD; COLORECTAL TUMOR; CONTROLLED STUDY; EARLY CANCER DIAGNOSIS; ECHOGRAPHY; FEMALE; HUMAN; LUNG TUMOR; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; OVARY TUMOR; PROCEDURES; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; SIGMOIDOSCOPY; THORAX RADIOGRAPHY;

AGED; CA-125 ANTIGEN; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MEMBRANE PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOGRAPHY, THORACIC; SIGMOIDOSCOPY; ULTRASONOGRAPHY;

EID: 85063945161     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141319839097     Document Type: Article

References (19)

1. Miller AB. Design of cancer screening trials/randomized trials for evaluation of cancer screening. World J Surg 2006; 30: 1152–1162.
2. Moss S. Design issues in cancer screening trials. Stat Methods Med Res 2010; 19: 451–461.
3. Prorok PC Marcus PM. Cancer screening trials: nuts and bolts. Semin Oncol 2010; 37: 216–223.
4. Black WC Haggstrom DA Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002; 94: 167–173.
5. Prorok PC Andriole GL Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21: 273S–309S.
6. Prorok PC Wright P Riley TR, et al. Overall and multiphasic findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial. Rev Recent Clin Trials 2018; 13: 257–273.
7. Schoen RE Pinsky PF Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2011; 366: 2345–2357.
8. Pinsky PF Prorok PC Yu K, et al. Extended mortality results for prostate cancer screening in the PLCO trial with median 15 years follow-up. Cancer 2017; 123: 592–599.
9. Pinsky PF Yu K Kramer BS, et al. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gyn Oncol 2016; 143: 270–275.
10. Oken M Hocking WG Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) randomized trial. JAMA 2011; 306: 1865–1873.
11. Pinsky PF Miller E Prorok P, et al. Extended follow-up for prostate cancer incidence and mortality among participants in the prostate, lung, colorectal and ovarian randomized cancer screening trial. BJUI. 2019; 123: 854–860
12. Miller E Pinsky PF Schoen RE, et al. Effect of flexible sigmoidoscopy on colorectal cancer incidence and mortality: long-term follow-up of the randomized US PLCO Cancer Screening Trial. Lancet Gastroenterol Hepatol 2019; 4: 101–110.
13. National Center for Health Statistics. National vital statistics reports, https://www.cdc.gov/nchs/products/nvsr.htm (2016, accessed 11 December 2018).
14. Buys SS Partridge E Black A, et al. Effect of screning on ovarian cancer mortality. JAMA 2011; 305: 2295–2303.
15. Pinsky P Black A Kramer BS, et al. Assessing contamination and compliance in the prostate component of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Clin Trials 2010; 7: 303–311.
16. Pinsky PF Freedman M Kvale P, et al. Abnormalities on chest radiograph reported in subjects in a cancer screening trial. Chest 2006; 130: 688–693.
17. Aberle DR Adams AM Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395–409.
18. Swartz AW Ebert JM Josey MJ, et al. Reanalysis of all-cause mortality in the U.S. Preventive Services Task Force 2016 evidence report on colorectal cancer screening. Ann Intern Med 2017; 167: 602–603.
19. Nelson HD Fu R Cantor A, et al. Effectiveness of breast cancer screening: systematic review to update the 2009 U.S. Preventive Services Task Force recommendation. Ann Intern Med 2016; 164: 244–255.